US approves AstraZeneca, Daiichi's treatment for lung cancer
June 24 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Tuesday that U.S. regulators have approved its precision drug Datroway to treat a type of lung cancer, adding that the drugmaker would now pay partner Daiichi Sankyo (4568.T), opens new tab $45 million in milestone-related considerations.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
20 minutes ago
- Daily Mail
The shocking new inventions that will completely change your hospital visits: From the 'twin' who will do your check-ups for you to the magic mirror that can diagnose you in under a minute
You wake in the morning at the perfect time in your sleep cycle, as your smart mattress is syncing with your calendar to give you a gentle shake at the optimal moment. Your smart pillow has adjusted itself through the night, rising up or down, based on your snuffles and snores to give you optimal sleep.
Reuters
27 minutes ago
- Reuters
Gates foundation to commit $1.6 billion for Gavi vaccine alliance
June 24 (Reuters) - The Gates Foundation said on Tuesday it will commit $1.6 billion over the next five years to support Gavi, a public-private partnership that helps buy vaccines for the world's poorest children. The number of kids dying around the world will likely go up this year because of the massive cuts to foreign aid, Bill Gates, the chair of the foundation, said in a statement, adding that funding Gavi was the single most powerful step to stop it. U.S. Health Secretary Robert F. Kennedy Jr, a long-time vaccine skeptic, is set to speak this week at a fundraising event for Gavi, Reuters reported on Monday, citing sources The Trump administration has previously indicated that it planned to cut its funding for Gavi.
Finextra
39 minutes ago
- Finextra
Wall Street and crypto firms pump $135 million into Digital Asset
Major players from crypto and traditional finance have joined in a $135 million funding round in Digital Asset, the firm behind the Canton Network blockchain platform for tokenised assets. 0 Led by DRW Venture Capital and Tradeweb Markets, the round includes participation from major institutions in both traditional and decentralized finance, including BNP Paribas, Circle Ventures, Citadel Securities, The Depository Trust & Clearing Corporation (DTCC), Goldman Sachs, IMC, Liberty City Ventures, Optiver, Paxos, Polychain Capital, QCP, Republic Digital, 7RIDGE, and Virtu Financial. The raise deepens the relationship with several firms who already part of the Canton Network, including, BNP Paribas, DRW, Goldman Sachs, Liberty City Ventures, QCP, and Tradeweb, all of whom have played various roles in either the testing, governance, infrastructure, or app development on the Network since its inception. Canton has experienced rapid growth over the past year, with nearly 400 ecosystem participants and hundreds of billions of real-world assets on the Network, building upon a substantial deployment of diverse asset classes, including bonds, money market funds, alternative funds, commodities, repurchase agreements (repos), mortgages, life insurance, and annuities. Yuval Rooz, co-founder and CEO of Digital Asset, comments: 'This funding milestone validates the inevitability of what we envisioned years ago: a privacy-enabled public blockchain designed specifically for institutional adoption. Canton is already actively supporting numerous asset classes-from bonds to alternative funds - and this raise will accelerate onboarding even more real-world assets, finally making blockchain's transformative promise an institutional-scale reality.'
